Featured Research

from universities, journals, and other organizations

Cell reprogramming to cure leukemia and lymphoma?

Date:
April 2, 2013
Source:
Centre for Genomic Regulation
Summary:
Researchers have reprogrammed lymphoma and leukemia cells to halt their malignancy. Resulting cells remained benign even when no longer subjected to treatment and patients were less likely to develop new tumors.

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce likelihood of developing new tumours.

Results are published in this week's edition of the scientific journal Cell Reports.

Leukemia and lymphoma are two types of cancer affecting blood cells. Both illnesses are widely studied and are currently treated mainly with chemotherapy, radiotherapy and antibodies in order to destroy the cancer cells. Unfortunately, there are still a considerable number of patients that do not respond to existing therapies. For this reason, the new discoveries published this week in Cell Reports journal could be very important for the future.

"Our experiments demonstrate that cancer cells in humans can be transdifferentiated (transformed) into similar normal cells. This discovery tests a new therapeutic strategy which allows blood diseases, like leukemia and lymphoma, to be treated," explains Thomas Graf, principal investigator on the project, group leader at the Centre for Genomic Regulation (CRG) and ICREA research professor.

Thomas Graf and his team had already shown that, thanks to the C/EBPα transcription factor, it is possible to reprogramme one type of blood cell to become another. Specifically, his work focused on changing lymphocytes into macrophages. Now this lab has been investigating the possibility of transforming cancerous blood cells into macrophages. The results have been very positive. The researchers have not only transdifferentiated malignant cells, but the reprogrammed cells also maintain their new state as macrophages over time and definitively. In addition, the scientists have been able to prove that the tumour generating capacity of immunosuppressed mice reduces drastically, which makes these new findings a very effective new treatment. In converting malignant cells into macrophages -a type of cell that does not divide- the work presented by Graf and his collaborators offers the possibility of a new type of treatment to combat blood cancer in the future. Even though the treatments used currently allow cancerous cells to be eliminated, they still do not reduce the capacity to generate new tumours.

"We must continue looking for ways to use what we have just discovered to benefit patients. Most importantly, we now know that human cancer cells can be successfully reprogrammed and also that the reprogramming decreases the possibility of the cancer reproducing. Now we are trying to find chemical compounds (or pharmaceuticals) with the same treatment capacity, not only in culture but also in patients," insists Thomas Graf.

The work includes the work of two Spanish labs. Thomas Graf, researcher at the Centre for Genomic Regulation (CRG), led the project and has been collaborating with the group of José A. Martínez-Climent from the Centre for Applied Medical Research (CIMA) at Navarra University. The project was funded by the Ministry of Education and Science and the Ministry of Health, through the Instituto de Salud Carlos III. The first author of the article, Francesca Rapino, holds a grant from the International PhD Programme funded by "La Caixa."


Story Source:

The above story is based on materials provided by Centre for Genomic Regulation. Note: Materials may be edited for content and length.


Journal Reference:

  1. Francesca Rapino, Eloy F. Robles, Jose A. Richter-Larrea, Eric M. Kallin, Jose A. Martinez-Climent, Thomas Graf. C/EBPα Induces Highly Efficient Macrophage Transdifferentiation of B Lymphoma and Leukemia Cell Lines and Impairs Their Tumorigenicity. Cell Reports, 2013; DOI: 10.1016/j.celrep.2013.03.003

Cite This Page:

Centre for Genomic Regulation. "Cell reprogramming to cure leukemia and lymphoma?." ScienceDaily. ScienceDaily, 2 April 2013. <www.sciencedaily.com/releases/2013/04/130402124539.htm>.
Centre for Genomic Regulation. (2013, April 2). Cell reprogramming to cure leukemia and lymphoma?. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2013/04/130402124539.htm
Centre for Genomic Regulation. "Cell reprogramming to cure leukemia and lymphoma?." ScienceDaily. www.sciencedaily.com/releases/2013/04/130402124539.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) — Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) — A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) — More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) — Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins